So far, rather preliminary results have been reported for RASSF1A methylation in relation to PC progression, and further studies are needed to investigate whether RASSF1A hypermethylation adds independent prognostic value to the established clinicopathological parameters. The gene discussed is RASSF1; the disease is pachyonychia congenita.